References:

[1]李月强, 刘晓琴, 韩敏, 等. 近 20 年肾脏病理谱变化趋势的回顾性分析 [ J]. 临床肾脏病杂志, 2014,14(7):410 - 414
[2]Alfaadhel T, Cattran D. Management of Membranous Ne-phropathy in Western Countries[ J]. Kidney Dis, 2015,1(2):126 - 137.
[3] Polanco N, Gutiérrez E, Covarsí A, et al. SpontaneousRemission of Nephrotic Syndrome in Idiopathic Membra-nous Nephropathy[J]. Journal of the American Society ofNephrology, 2010,21(4):697 - 704.
[4]Chan C K, Lai T S, Chen P M, et al. Early initiation ofimmunosuppressive treatment in membranous nephropathypatients. [ J]. Journal of the Formosan Medical Associa-tion, 2017,116(4):266 - 275.
[5 ] Ponticelli C, Altieri P, Scolari F, et al. A randomizedstudy comparing methylprednisolone plus chlorambucil ver-sus methylprednisolone plus cyclophosphamide in idiopath-ic membranous nephropathy. [J]. Journal of the AmericanSociety of Nephrology Jasn, 1998,9(3):444 - 450.
[6 ] Praga M, Barrio V, Ju? Rez G F, et al. Tacrolimusmonotherapy in membranous nephropathy: a randomizedcontrolled trial[ J]. Kidney International, 2007,71 (9):924 - 930.
[7] Nishi S. [ Guidelines for the treatment of nephrotic syn-drome]. [J]. Nihon Jinzo Gakkai Shi, 2014,56(4):518- 523.
[8]Cui W, Lu X, Min X, et al. Therapy of tacrolimus com-bined with corticosteroids in idiopathic membranous ne-phropathy. [J]. Brazilian Journal of Medical & BiologicalResearch, 2017,50(4):e5976.
[9]Dong H S, Mi J L, Oh H J, et al. Stepwise Treatment U-sing Corticosteroids Alone and in Combination with Cyclos-porine in Korean Patients with Idiopathic Membranous Ne-phropathy[J]. Yonsei Medical Journal, 2013,54(4):973- 982.
[10]Ejaz A A, Asmar A, Alsabbagh M M, et al. Rituximabin immunologic glomerular diseases [ J]. Mabs, 2012,4(2):198 - 207.
[11]Wang X, Cui Z, Zhang Y M, et al. Rituximab for non -responsive idiopathic membranous nephropathy in a Chi-nese cohort. [ J]. Nephrology, dialysis, transplantation :official publication of the European Dialysis and TransplantAssociation - European Renal Association, 2017.
[12] 杜义斌. 叶任高治疗膜性肾病型肾病综 合 征 经 验[J]. 中医杂志, 2001,8(8):461 - 462.
[13]董正华. 杜雨茂教授运用六经辨证辨治肾病综合征经验[C]: 全国第二十一次仲景学说学术年会, 中国福建福州, 2013.
[14] 董兴刚. 陈以平教授辨证分型治疗膜性 肾 病 经 验[J]. 疑难病杂志, 2002,3(3):175.
[15]伍罛, 胡庆全. 陈以平治疗膜性肾病经验[ J]. 中医杂志, 2001,7(7):401 - 402.
[16]刘玉宁, 邓跃毅, 杜兰屏. 陈以平教授治疗膜性肾病的经验[J]. 中国中西医结合肾病杂志, 2004,3 (3):131 - 132.
[17]刘玉宁, 郭立中, 王立红. 叶传蕙教授治疗原发性肾病综合征 的 经 验 [ J ]. 中 国 中 西 医 结 合 肾 病 杂 志,2002,8(8):439 - 441.
[18]白艳洁, 王文凤, 杨霓芝. 杨霓芝教授治疗原发性肾病综合征临床经验介绍[ J]. 中国中西医结合肾病杂志, 2017,18(2):100 - 101.
[19]余仁欢. 聂莉芳教授治疗膜性肾病的经验[ J]. 西部中医药, 2011,24(9):25 - 27.
[20]杨小翠, 欧阳晃平. 聂莉芳教授治疗原发性肾病综合征经验[J]. 中国中西医结合肾病杂志, 2006,8 (8):376 - 377.
[21]时振声, 黄文政, 吕仁和, 等. 蛋白尿的中医辨治[J]. 北京中医, 1990,32(2):9 - 13.
[22]王鑫. 吕仁和教授临证经验及学术思想浅析[D]. 北京:北京中医药大学, 2013.
[23]裴超成, 叶任高. 叶任高治疗肾病综合征的经验[ J].中国中西医结合杂志, 2001,3(3):221 - 222.
[24]陈国姿, 田锦鹰. 叶任高教授从“瘀”论治肾病的学术思想[J]. 中华中医药学刊, 2008,8(8):1747 - 1748.
[25] 高志卿, 邓跃毅, 王琳, 等. 陈以平教授分期论治膜性肾病[J]. 上海中医药杂志, 2004,2(2):35 - 36.
[26] 杨永超, 刘晓春, 马宝梅, 等. 叶传蕙教授治疗特发性膜性肾病经验[J]. 陕西中医, 2015,36(1):78 - 80.
[27]左琪, 包崑, 杨霓芝. 杨霓芝教授治疗特发性膜性肾病的经验[J]. 中医药导报, 2014,20(3):8 - 11.